Get started
Author

Rong He

ORCID: 0009-0001-5611-7078
Observed ORCID: 0009-0001-5611-7078
OpenAlex ID: A5023318060
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
2023 · Ji Yuan, Rong He, et al. · Current Hematologic Malignancy Reports · 11
PDF
Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion
2024 · Jeffrey Wang, Weiwei Zhang, et al. · Human Pathology · 7
Prevalence of Concurrent (Double‐Positive) JAK2 , CALR , or MPL Mutations and Corresponding Clinicopathologic Features: Analysis of 21556 Mayo Clinic NGS Studies Including 2651 Informative Cases
2025 · Rong He, Paul L. Ollila, et al. · American Journal of Hematology · 4
PDF
PPM1D Somatic Mutations in Myeloid Neoplasms: Clinical Profile, Clonal Characteristics and Impact of Concurrent Somatic TP53 Mutations
2024 · Talha Badar, Mobachir El Kettani, et al. · Blood · 4
PDF
Clinical Outcome and Molecular Profile in Patients with DDX41 Mutation Hot-Spots
2025 · Nadia Toumeh, Yazan Jabban, et al. · Hematology Reports · 3
PDF
Applicability of current prognostication models for MDS patients with DDX41 mutation
2025 · Nadia Toumeh, Yazan Jabban, et al. · Leukemia Research · 2
A Clinical Overview of Clonal Cytopenia of Undetermined Significance in the Presence of ZRSR2 Mutations
2024 · Mahmoud Yacout, Bahga Katamesh, et al. · Blood · 2
PDF
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance
2024 · Ayalew Tefferi, Maymona Abdelmagid, et al. · Blood · 2
PDF
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity
2026 · Niki M. Zacharias, Eric S. Rupe, et al. · Clinical Cancer Research · 1
PDF
Blast Clearance Dynamics and Time to Response Across IDH1‐ and IDH2 ‐Mutated AML
2025 · Mohamad Sheikh Najeeb, Oudai Alkabbani, et al. · eJHaem · 1
PDF
Evidence-Based Risk Stratification of TP53-Mutated Myeloid Neoplasms
2024 · Mithun V Shah, Kevin Hung, et al. · Blood · 1
Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)
2024 · Qian Cheng, JingWen Tan, et al. · Blood · 1
Basophilia in Polycythemia Vera Is Associated with an Increased Risk of Leukemic and Myelofibrotic Transformation
2024 · Mahlet Siraga, Maymona Abdelmagid, et al. · Blood · 1
P747: Clinical Characteristics and Outcome of Ezh2-mutated Myeloid Neoplasms: Mayo Clinic Experience
2023 · Muhamad Oum, Ahmad Nanaa, et al. · HemaSphere · 1
Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations
2022 · Yenny Moreno Vanegas, Ahmad Nanaa, et al. · Blood · 1
Characteristics and Outcomes of Patients with BCOR Mutated Myeloid Neoplasms
2022 · Anmol Baranwal, Mithun V. Shah, et al. · Blood · 1
Autoimmune manifestations in STAG2-mutated myeloid neoplasms
2022 · Bahga Katamesh, Ahmad Nanaa, et al. · Annals of Hematology · 1
POSTER: MPN-850: Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis
2026 · Emma St Martin, Clifford Csizmar, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MPN-715: Clinical and Molecular Characteristics of Clonal Monocytosis With and Without Cytopenias
2026 · Tariq Kewan, Hadil Zureigat, et al. · Clinical Lymphoma Myeloma & Leukemia
MPN-850: Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis
2026 · Emma St Martin, Clifford Csizmar, et al. · Clinical Lymphoma Myeloma & Leukemia
MPN-715: Clinical and Molecular Characteristics of Clonal Monocytosis With and Without Cytopenias
2026 · Tariq Kewan, Hadil Zureigat, et al. · Clinical Lymphoma Myeloma & Leukemia
Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations
2026 · Mahmoud Yacout, Bahga Katamesh, et al. · Haematologica
PDF
ICC / WHO ‐Defined and NGS ‐Annotated Idiopathic Hypereosinophilia ( iHES / iHE ): Mutations, Clinical and Treatment Details, and Predictors of Survival
2026 · Shraddha P. Patel, Muhammad Yousuf, et al. · American Journal of Hematology
PDF
Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significance
2026 · Yazan Jabban, Rong He, et al. · Haematologica
PDF
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significance
2026 · Yazan Jabban, Rong He, et al. · British Journal of Haematology
Works count: 46
Citation count: 44
H-index: 4
I10-index: 1
Year
Topic
Type